PubRank

R J Duquesnoy

Author PubWeight™ 117.05‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Functional characterization of infiltrating T lymphocytes in human hepatic allografts. Hum Immunol 1986 2.84
2 Allospecificity of activated T cells grown from endomyocardial biopsies from heart transplant patients. Transplantation 1986 2.82
3 Clonal dominance among T-lymphocyte infiltrates in arthritis. Proc Natl Acad Sci U S A 1988 2.36
4 Specificity of alloactivated human T lymphocyte clones in secondary proliferation, cell-mediated lympholysis and interleukin-2 release. J Immunogenet 1985 1.82
5 Interactions between bronchoalveolar lymphocytes and macrophages in heart-lung transplant recipients. Hum Immunol 1985 1.65
6 Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect? Transplantation 1988 1.61
7 Identification of an HLA-DR-associated system of B-cell alloantigens. Transplant Proc 1979 1.57
8 Obliterative bronchiolitis after lung and heart-lung transplantation. An analysis of risk factors and management. J Thorac Cardiovasc Surg 1995 1.48
9 Analysis of chronic rejection and obliterative arteriopathy. Possible contributions of donor antigen-presenting cells and lymphatic disruption. Am J Pathol 1997 1.41
10 Molecular relationships of the human B cell alloantigens, MT2, MB3, MT4, and DR5. J Immunol 1982 1.34
11 Sensitivity of activated human lymphocytes to cyclosporine and its metabolites. Hum Immunol 1988 1.31
12 Alloreactive T-cell recognition of two DQ beta allelic specificities associated with DQw1. Hum Immunol 1987 1.26
13 Heart-lung transplantation: lessons learned and future hopes. Ann Thorac Surg 1987 1.23
14 Dynamics of allospecific T lymphocyte infiltration in vascularized human allografts. Immunol Res 1986 1.20
15 Serological and cellular definition of a new HLA-DR associated determinant, MC1, and its association with rheumatoid arthritis. Hum Immunol 1984 1.19
16 Cytomegalovirus serologic status and postoperative infection correlated with risk of developing chronic rejection after pulmonary transplantation. Transplantation 1991 1.13
17 Expression of HLA-B12, HLA-B8, w4, and w5 on platetelets. Transplant Proc 1977 1.10
18 Cytokine mRNA profiles in mouse orthotopic liver transplantation. Graft rejection is associated with augmented TH1 function. Transplantation 1995 1.10
19 Three Ia species with different structures and alloantigenic determinants in an HLA-homozygous cell line. J Exp Med 1983 1.10
20 HLA-DR associations in black type I diabetics in Nigeria. Further support for models of inheritance. Diabetes 1986 1.08
21 Bioassay of plasma specimens from liver transplant patients on FK 506 immunosuppression. Transplant Proc 1990 1.08
22 Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations. Arthritis Rheum 1992 1.07
23 Population studies of the HLA-linked SB antigens. Immunogenetics 1981 1.06
24 Association of HLA-DRw2 antigen with presumed ocular histoplasmosis. Am J Ophthalmol 1980 1.05
25 Association of PLT specificity of alloreactive lymphocyte clones with HLA-DR, MB and MT determinants. Immunogenetics 1982 1.04
26 Immunological studies of the Snell-Bagg pituitary dwarf mouse. Proc Soc Exp Biol Med 1970 1.04
27 Influence of panel-reactive antibody and lymphocytotoxic crossmatch on survival after heart transplantation. J Heart Lung Transplant 1992 1.02
28 Platelet migration inhibition: a new method for detection of platelet antibodies. Blood 1975 1.01
29 Analysis of T lymphocytes infiltrating human hepatic allografts. Transplant Proc 1987 1.00
30 Increased lymphocyte adherence to human arterial endothelial cell monolayers in the context of allorecognition. J Immunol 1990 1.00
31 Immunologically mediated disease of the airways after pulmonary transplantation. Ann Surg 1988 1.00
32 Intraoperative blood transfusions in highly alloimmunized patients undergoing orthotopic liver transplantation. Transplantation 1989 0.98
33 Thymus adenylate cyclase activity during murine leukemogenesis. Science 1974 0.97
34 Recognition of major histocompatibility complex antigens on cultured human biliary epithelial cells by alloreactive lymphocytes. Hepatology 1991 0.96
35 The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation. Transplantation 1993 0.95
36 Lymphocyte growth from cardiac allograft biopsy specimens with no or minimal cellular infiltrates: association with subsequent rejection episode. J Heart Transplant 1989 0.95
37 Immunodeficiency of the thymus-dependent system of the Ames dwarf mouse. J Immunol 1972 0.94
38 Propagation of lymphocytes infiltrating human liver allografts. Correlation with histologic diagnosis of rejection. Transplantation 1990 0.93
39 Functional differentiation of human cytotoxic T lymphocytes in the presence of FK 506 and CyA. Transplant Proc 1990 0.93
40 Demonstration of a third structurally distinct human Ia beta chain by two-dimensional gel electrophoresis. J Exp Med 1982 0.92
41 Successful transfusion of platelets "mismatched" for HLA antigens to alloimmunized thrombocytopenic patients. Am J Hematol 1977 0.92
42 Effect of hypophysectomy on immunological recovery after sublethal irradiation of adult rats. Proc Soc Exp Biol Med 1969 0.91
43 Serologic studies in a family with heterozygous C2 deficiency. Am J Med 1981 0.90
44 Lymphocytes of bronchoalveolar lavages from heart-lung transplant recipients. J Heart Transplant 1987 0.89
45 High-dose intravenous gamma globulin improves responses to single-donor platelets in patients refractory to platelet transfusion. Blood 1987 0.88
46 Endocrinological studies in ataxiatelangiectasia and other immunological deficiency diseases. Clin Exp Immunol 1970 0.88
47 HLA-DR specificities among black Americans with juvenile-onset diabetes. N Engl J Med 1979 0.88
48 Dissociation in expression of MB1/MT1 and DR1 alloantigens in mutants of a lymphoblastoid cell line. J Immunol 1983 0.87
49 Heat shock protein reactivity of lymphocytes isolated from heterotopic rat cardiac allografts. Transplantation 1995 0.87
50 Immunogenetic aspects of the relationship between HLA-DR and the MB and MT system. Transplant Proc 1981 0.87
51 Association of the B-cell alloantigen MBI with HLA-DRw1 and DRw2. Transplant Proc 1980 0.87
52 Pulmonary arteriosclerosis in long-term human heart-lung transplant recipients. Transplantation 1989 0.87
53 HLA antigen expression on cultured human arterial endothelial cells. Tissue Antigens 1988 0.86
54 Proliferative responses of bronchoalveolar lavage lymphocytes from heart-lung transplant patients. Transplantation 1990 0.86
55 Comparative in vitro studies on the immunosuppressive activities of mycophenolic acid, bredinin, FK 506, cyclosporine, and rapamycin. Transplant Proc 1991 0.86
56 Effects of FK 506 and cyclosporine on T-cell activation: integrin-mediated adhesion of T cells, proliferation, and maturation of cytotoxic T cells. Transplant Proc 1991 0.85
57 Combined liver-kidney transplantation and the effect of preformed lymphocytotoxic antibodies. Transpl Immunol 1994 0.85
58 The influence of HLA donor-recipient compatibility on the recurrence of HBV and HCV hepatitis after liver transplantation. Transplantation 1995 0.84
59 HLA histocompatibility and liver transplant survival. Transplant Proc 1987 0.84
60 The complexity of HLA-DS molecules. A homozygous cell line expresses multiple HLA-DS alpha chains. J Exp Med 1984 0.84
61 Effect of HLA Bw4/Bw6 compatibility on platelet transfusion responses of refractory thrombocytopenic patients. Blood 1982 0.83
62 Species differences in sensitivity of T lymphocytes to immunosuppressive effects of FK 506. Transplantation 1990 0.83
63 Adherence of alloreactive lymphocytes to human arterial endothelial cell monolayers. Clin Exp Immunol 1989 0.83
64 DQ alpha and beta RFLP reveals the composition of the DQ molecule recognized by T-cell clones. Immunogenetics 1986 0.83
65 Immunoglobulin G lymphocytotoxic antibodies in clinical liver transplantation: studies toward further defining their significance. Hepatology 1995 0.83
66 Unexpectedly high incidence of Pneumocystis carinii infection after lung-heart transplantation. Implications for lung defense and allograft survival. Am Rev Respir Dis 1988 0.83
67 Interleukin-2 and interleukin-12 mediate distinct effector mechanisms of liver allograft rejection. Liver Transpl Surg 1997 0.83
68 Detection of non-HLA-DR determinants by alloreactive lymphocyte clones. Hum Immunol 1983 0.83
69 HLA phenotype of lung lavage cells following heart-lung transplantation. J Heart Transplant 1987 0.83
70 Distribution of HLA antigens in Polish and German populations in Milwaukee, Wisconsin. Am J Phys Anthropol 1978 0.82
71 Alterations in HLA-DP and HLA-DQ antigen frequency in patients with dermatitis herpetiformis. J Invest Dermatol 1989 0.82
72 Propagation of alloreactive lymphocytes from histologically negative endomyocardial biopsies from heart transplant patients. Association with subsequent histological evidence of allograft rejection. Transplantation 1989 0.82
73 Mouse liver transplantation tolerance: the role of hepatocytes and nonparenchymal cells. Transplant Proc 1995 0.82
74 Association of MB compatibility with successful intrafamilial kidney transplantation. N Engl J Med 1980 0.81
75 Linkage disequilibrium of HLA-SB1 with the HLA-A1, B8, DR3, SCO1 and of HLA-SB4 with the HLA-A26, Bw38, Dw10, DR4, SC21 extended haplotypes. Immunogenetics 1984 0.81
76 Increased responsiveness to phytohemagglutinin and graft-vs-host reactivity of thymus cells from Snell-Bagg dwarf mice. J Immunol 1973 0.81
77 IL-2-augmented primed-lymphocyte test responses of lymphocytes cultured from endomyocardial biopsies from heart transplant patients. Transplantation 1992 0.81
78 Association of HLA Compatibility and Decreased Liver Transplant Survival. Transplant Proc 1988 0.81
79 Sequential infiltration of class I and class II specific alloreactive T cells in human cardiac allografts. Transplant Proc 1987 0.81
80 Functional differences between cells from MLR colonies grown in soft agar cultures. J Immunol 1980 0.81
81 Relationship between DQ alpha and DQ beta RFLP and cell surface polymorphisms of class II HLA antigens. J Immunogenet 1987 0.80
82 Association between HLA-D region antigens and disease-free survival in childhood non-T, non-B acute lymphocytic leukemia. Blood 1982 0.80
83 Presence of donor-specific alloreactivity in histologically normal lung allografts is predictive of subsequent bronchiolitis obliterans. Transplant Proc 1991 0.80
84 Histocompatibility and other risk factors for histological rejection of human cardiac allografts during the first three months following transplantation. Transplantation 1991 0.80
85 Mitogen responses of lymphocytes from lung transplant recipients--correlation with rejection and infection. Transplantation 1992 0.79
86 Intraoperative blood transfusion requirements and deficient hemostasis in highly alloimmunized patients undergoing liver transplantation. Transplant Proc 1988 0.79
87 Fate of Brucella abortus in neonatally thymectomized rats. Int Arch Allergy Appl Immunol 1969 0.79
88 T lymphocyte infiltrates in inflammatory synovia are oligoclonal. Transplant Proc 1988 0.79
89 Association between donor-recipient HLA-DR compatibility and cytomegalovirus hepatitis and chronic rejection in liver transplantation. Transplant Proc 1993 0.79
90 Heat shock protein-induced T-lymphocyte propagation from endomyocardial biopsies in heart transplantation. J Heart Lung Transplant 1995 0.79
91 Interactions between endothelial cells and alloreactive T cells involved in allograft immunity. Transplant Proc 1988 0.79
92 Adult rheumatoid arthritis is associated with MC1, a new HLA-D encoded determinant. J Rheumatol 1988 0.78
93 Comparative in vitro studies on the immunosuppressive effects of purine and pyrimidine synthesis inhibitors. Transplant Proc 1993 0.78
94 A linkage study of the HLA region using C-band heteromorphisms. Clin Genet 1983 0.78
95 Genetic, immunological, and metabolic determinants of risk for type 1 diabetes mellitus in families. Diabet Med 1992 0.78
96 Mitogen responses and T4/T8 ratios in asymptomatic hemophiliac patients. Transfusion 1985 0.78
97 Lymphoid cell adenylate cyclase activity after x-irradiation and cortisone treatment. J Immunol 1975 0.78
98 Primed lymphocyte testing specificity of alloreactive lymphocyte clones for HLA-B locus determinants. Proc Natl Acad Sci U S A 1983 0.78
99 Usefulness of typing for w4 and w6 specificities in HLA serology. Transplant Proc 1977 0.77
100 Increased radiosensitivity of stimulator cells in the human mixed leucocyte culture reaction and the secondary response of primed lymphocytes. Clin Exp Immunol 1981 0.77
101 In vitro culture of infiltrating lymphocytes from coronary arteries and endomyocardial biopsies: association with graft coronary disease. Transplant Proc 1991 0.77
102 Heterogeneity of cytolytic and suppressor clones of alloactivated cells generated from soft agar colonies. Hum Immunol 1982 0.77
103 Expression of stress proteins and lymphocyte reactivity in heterotopic cardiac allografts undergoing cellular rejection. Transpl Immunol 1995 0.77
104 Further studies of the expression of Bw4, Bw6, and other antigens of the HLA-B locus on human platelets. Transplant Proc 1978 0.77
105 Kidney transplantation in Pittsburgh: experience and innovations. Clin Transpl 1987 0.77
106 Decreased epinephrine response of adenylate cyclase activity of lymphoid cells from immunodeficient pituitary dwarf mice. J Immunol 1973 0.77
107 Propagation of infiltrating lymphocytes and graft coronary disease in cardiac transplant recipients. Hum Immunol 1990 0.77
108 Correlations between Terasaki's HLA class II epitopes and HLAMatchmaker-defined eplets on HLA-DR and -DQ antigens. Tissue Antigens 2009 0.77
109 Rapid screening for hepatitis antigen by immunoelectrodiffusion using paper discs. Transfusion 1970 0.76
110 Phenotypic and functional characteristics of colonic lymphocytes isolated from patients with primary sclerosing cholangitis and inflammatory bowel disease. Hepatogastroenterology 1995 0.76
111 Serological analysis of the HL--A10 complex. Tissue Antigens 1976 0.76
112 Serologic analysis of the HLA-A10 complex. II. Absorption studies on Aw25, Aw26, and Aw34. Transplant Proc 1977 0.76
113 Influence of HLA-A2 on the effectiveness of platelet transfusions in alloimmunized thrombocytopenic patients. Blood 1977 0.76
114 Immunogenetic analysis of the HLA-D region: serological and cellular detection of the MB system. Clin Immunol Immunopathol 1982 0.76
115 The pituitary dwarf mouse: a model for study of endocrine immunodeficiency disease. Birth Defects Orig Artic Ser 1975 0.76
116 Propagation of lymphocytes from human heart transplant biopsies: methodologic considerations. Transplant Proc 1988 0.76
117 Lymphocyte activation in bronchoalveolar lavages from heart-lung transplant recipients. Transplant Proc 1988 0.76
118 Role of HLA-C matching in histocompatible platelet transfusion therapy of alloimmunized thrombocytopenic patients. Transplant Proc 1977 0.76
119 Role of HLA antigens in liver transplantation with special reference to cellular immune reactions. Langenbecks Arch Surg 1998 0.76
120 Plasmapheresis in the treatment of renal allograft rejection. Proc Clin Dial Transplant Forum 1979 0.76
121 Persistence of donor-reactive T cells after liver transplantation-induced tolerance in mice. Transplant Proc 1993 0.76
122 Mitogen- and alloantigen-stimulated blastogenic responses of dinitrophenyl-modified human lymphocytes. Immunology 1982 0.75
123 Allospecificity of liver allograft-derived lymphocytes and correlation with clinicopathologic findings. Transplant Proc 1988 0.75
124 Identification of two types of autoreactive T lymphocyte clones cultured from cardiac allograft-infiltrating cells incubated with recombinant mycobacterial heat shock protein 71. Transpl Immunol 1997 0.75
125 Definition of HLA-DQ polymorphisms by RFLP and in serological and cellular assays. Transplant Proc 1987 0.75
126 Transfusion strategy: use of HLA-matched platelet transfusions for alloimmunized patients. Am J Med Technol 1981 0.75
127 The immunosuppressive activity of the aldehydic transformation of cyclosporine on alloreactive T-cells. J Clin Pharmacol 1991 0.75
128 Propagation and characterization of lymphocytes infiltrating livers of patients with primary biliary cirrhosis and autoimmune hepatitis. Hum Immunol 1990 0.75
129 Suitability of liquid-stored donor platelets in platelet compatibility testing. Transfusion 1989 0.75
130 Transient appearance of HLA-DRw-positive leukocytes in peripheral blood after cessation of antileukemia therapy. Transplant Proc 1980 0.75
131 Role of heat shock proteins in heart transplant rejection. J Heart Lung Transplant 1996 0.75
132 Progress report on the ASHI/CAP Proficiency Survey Program in Histocompatibility Testing. I. HLA-A,B,C typing, antibody screening, and lymphocytotoxicity crossmatching. American Society for Histocompatibility and Immunogenetics. College of American Pathologists. Hum Immunol 1994 0.75
133 Detection of HLA-DR associated PLT determinants by alloreactive lymphocyte clones. Immunogenetics 1983 0.75
134 High prevalence of HLA-B27, Cw1 and Cw2 in patients with seronegative spondyloarthritis. Tissue Antigens 1978 0.75
135 Unusual MLC responses of black patients with juvenile-onset diabetes. Transplant Proc 1979 0.75
136 HLA types in American black juvenile diabetics strong associations with Dw3 and Dw4. Metabolism 1981 0.75
137 Changes in lymphoid cyclic adenosine 3':5'-monophosphate metabolism during murine leukemogenesis. Cancer Res 1975 0.75
138 Functional studies of in vivo committed lymphocytes propagated from organ transplants. Prog Clin Biol Res 1986 0.75
139 Immunogenetic analysis of the HLA complex with alloreactive T cell clones. Hum Immunol 1983 0.75
140 Recent developments in HLA typing. Prog Clin Biol Res 1982 0.75
141 Rapid quantitation of the immunopreciptin reaction in agarose gel by electroimmunodiffusion with paper discs. J Immunol Methods 1973 0.75
142 Characterization of the biopsy growth assay in monitoring cardiac transplant patients for rejection. Transplant Proc 1993 0.75
143 Bronchoalveolar macrophage-lymphocyte reactivity in heart-lung transplant recipients. Transplant Proc 1987 0.75
144 HLA-DR antigens in Black North-Americans and their association with HLA-D. Tissue Antigens 1979 0.75
145 Predictive value of cross-matching for transfusion of platelet concentrates to alloimmunized recipients. Am J Hematol 1976 0.75
146 Association of presumed ocular histoplasmosis with HLA-B7 and DRw2. Transplant Proc 1979 0.75
147 Congenital neutropenia: studies of pathogenesis. Am J Hematol 1980 0.75
148 The use of estrone-protein conjugates in the study of the in vivo fate of antigen. Life Sci 1969 0.75
149 In vitro studies of endomyocardial biopsies from heart transplant recipients on RATG and OKT3 immunoprophylaxis protocols. Transplantation 1989 0.75
150 Inhibitory effect of growth hormone on Gross passage A virus-induced thymus leukemia in C3Hf mice. Cancer Res 1979 0.75
151 Intravenous gamma globulin decreases platelet-associated IgG and improves transfusion responses in platelet refractory states. Am J Hematol 1991 0.75
152 Growth inhibition of newborn rats by plasma of monkeys immunized against rat growth hormone. J Endocrinol 1970 0.75
153 Monoclonal antibody analysis of responder and stimulator cells in the human autologous mixed lymphocyte reaction. Immunobiology 1984 0.75
154 Diminished lymphocyte growth from endomyocardial biopsies from cardiac transplant patients on FK 506 immunosuppression. Transplant Proc 1991 0.75
155 HLA-DQ polymorphism analyzed by sequential restriction endonuclease DNA digestion. Immunogenetics 1986 0.75
156 Bone marrow transplantation for severe aplastic anemia using a phenotypically HLA-identical, SB-compatible unrelated donor. Transplantation 1983 0.75
157 Prevention of immunologic deficiency in pituitary dwarf mice by prolonged nursing. J Immunol 1970 0.75
158 Association between HLA and diseases: an overview. Cutis 1980 0.75
159 Variable expression of w4 and w6 on platelets: possible relevance to platelet transfusion therapy of alloimmunized thrombocytopenic patients. Transplant Proc 1977 0.75
160 Immunological factors influencing liver graft survival. Gastroenterol Clin North Am 1988 0.75
161 Transfer of HLA antigens from stimulatory B cells to alloreactive T lymphocytes: a novel mechanism of "allospecific" autoregulation. Transplant Proc 1999 0.75
162 Immunologic mechanisms of cardiac transplant rejection. Cardiovasc Clin 1990 0.75
163 Heterogeneity of human T-lymphocyte clones generated from autologous mixed-lymphocyte cultures. Clin Immunol Immunopathol 1984 0.75
164 Increased frequency of HLA--Dw3 in North-American black patients with juvenile onset diabetes. Tissue Antigens 1979 0.75
165 Donor availability for platelet transfusion support of alloimmunized thrombocytopenic patients. Transplant Proc 1977 0.75